Left Atrial Appendage Occlusion
📧 Sign up to get email alerts when something new happens for Left Atrial Appendage Occlusion.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion [Phase 4]
A Phase 4 clinical trial evaluates how different anti-thrombotic strategies affect the incidence of silent cerebral embolism after percutane…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA) [Phase 4]
Phase 4 trial comparing apixaban to dual antiplatelet therapy after left atrial appendage occlusion has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion [Phase 4]
Phase 4 trial evaluating different antithrombotic strategies to prevent device-related thrombosis after percutaneous left atrial appendage o…
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion [Phase 4]
Phase 4 trial exploring the safety and efficacy of bivalirudin in reducing bleeding risk during left atrial appendage occlusion across multi…